Regulus Therapeutics Inc (RGLS)
2.27
+0.05
(+2.25%)
USD |
NASDAQ |
Apr 25, 16:00
2.29
+0.02
(+0.88%)
After-Hours: 20:00
Regulus Therapeutics Cash from Investing (TTM): 14.49M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 14.49M |
September 30, 2023 | 20.03M |
June 30, 2023 | 12.60M |
March 31, 2023 | -0.019M |
December 31, 2022 | -15.12M |
September 30, 2022 | -25.63M |
June 30, 2022 | -12.79M |
March 31, 2022 | -0.30M |
December 31, 2021 | -0.251M |
September 30, 2021 | -0.21M |
June 30, 2021 | -0.195M |
March 31, 2021 | -0.064M |
December 31, 2020 | -0.011M |
September 30, 2020 | -0.07M |
June 30, 2020 | -0.20M |
March 31, 2020 | -0.087M |
December 31, 2019 | 0.074M |
September 30, 2019 | 6.573M |
June 30, 2019 | 19.64M |
March 31, 2019 | 35.24M |
December 31, 2018 | 46.52M |
September 30, 2018 | 44.48M |
June 30, 2018 | 7.751M |
Date | Value |
---|---|
March 31, 2018 | 7.015M |
December 31, 2017 | 13.94M |
September 30, 2017 | 24.92M |
June 30, 2017 | 51.66M |
March 31, 2017 | 41.98M |
December 31, 2016 | 35.31M |
September 30, 2016 | 32.97M |
June 30, 2016 | 35.53M |
March 31, 2016 | 40.56M |
December 31, 2015 | 21.48M |
September 30, 2015 | -30.41M |
June 30, 2015 | -27.33M |
March 31, 2015 | -26.11M |
December 31, 2014 | -29.21M |
September 30, 2014 | 3.268M |
June 30, 2014 | -32.81M |
March 31, 2014 | -35.62M |
December 31, 2013 | -40.89M |
September 30, 2013 | -79.26M |
June 30, 2013 | -43.25M |
March 31, 2013 | -52.26M |
December 31, 2012 | -30.38M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-25.63M
Minimum
Sep 2022
20.03M
Maximum
Sep 2023
0.9717M
Average
-0.07M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
ACADIA Pharmaceuticals Inc | 32.00M |
ADMA Biologics Inc | -4.981M |
FibroGen Inc | 153.66M |
Protara Therapeutics Inc | 53.11M |
Amylyx Pharmaceuticals Inc | 92.05M |